Acquired LHP Chris Sale and cash considerations from Boston Red Sox for INF Vaughn Grissom.

Contract Value Index (CVI)

The trade for Chris Sale earns a D Contract Value Index (CVI) — a stark indictment of the value proposition, not the pitcher's talent. Sale is a franchise-caliber left-hander whose pedigree is unquestioned, but the CVI reflects a brutal reality: Atlanta surrendered future roster flexibility and prospect capital for a pitcher on the wrong side of his age curve, saddled with injury risk that has defined his recent seasons. Without contract specifics in the public record here, the leverage tilts decisively toward Boston, who offloaded a high-salary obligation onto a contender in win-now mode while the Braves absorbed the financial and health risk. The transaction makes sense for a team sitting atop the division with 112 days until the playoff sprint — Sale's front-line upside is real — but the CVI penalty reflects what the market has already priced in: you're paying ace money for ace availability, and availability has not been Sale's calling card. For a club eyeing October, it's a calculated gamble; for the ledger, it's a deal that trades present-day competitiveness for long-term balance. The steady A+ sentiment around the Braves' season suggests fans and media view this as a deadline desperation play that's defensible given the stakes, but the CVI grade captures the structural imbalance.